A synthetic version of the psychedelic drug ibogaine appears to relieve depression and addiction without producing hallucinations or other dangerous side effects — at least in rodents.

The federal government has released detailed local data on where hospitals are starting to fill up with patients. Researchers and health leaders say this was urgently needed.

Researchers found that a class of antibodies in a monkey's blood provides protection from COVID-19. If that hold true for humans, a blood test may predict whether a vaccine candidate is working.

The Pfizer-BioNTech COVID-19 vaccine was developed fast. But a leading vaccine expert says its important for consumers to know the companies "haven't cut corners" in the clinical science.

A federal advisory committee to the CDC voted Tuesday on guidelines for who should get COVID-19 vaccines first. The committee decided to prioritize health care workers and nursing home residents.

The biotech company has new data reinforcing that its COVID-19 inoculation is safe and effective. Moderna is submitting an application to the FDA requesting emergency use authorization.

Hospitals are getting so crowded with COVID-19 patients that they're having to resort to workarounds to treat them all. Experts warn this may hamper doctors' ability to save lives.

The medicines from Eli Lilly and Regeneron are infused, a process that can take two hours or longer, including observation for side effects. Staffing is as big an issue as the supply of the drugs.

A newly approved drug can extend the lives of children with progeria, a rare disorder that causes rapid aging. The drug is the result of one family's effort to help a child with the fatal condition.

The vaccine was found to be 95% effective in an updated study analysis. Safety data required by the Food and Drug Administration showed no serious concerns, the company said.

More than half of labs are reporting they're running short on test kits, pipettes and crucial chemicals.

One of the two leading vaccine candidates requires deep, deep freezing. Here's how communities are working to solve for this and how the new Moderna vaccine could help.

The vaccine is nearly 95% effective in preventing illness, according to an interim analysis of a clinical test involving 30,000 people.

The $1.6 billion Novavax contract is one of several Operation Warp Speed agreements issued through a third party, Advanced Technology International, and that hadn't been released.

Eli Lilly's monoclonal antibody will be available to people 65 or older or those with underlying health conditions. Supplies will be short, and allocating the medicine will be a challenge.